Canal Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
6,524
-918
-12% -$39.4K 0.04% 184
2026
Q1
$273K Hold
7,442
0.04% 176
2025
Q4
$379K Sell
7,442
-2,626
-26% -$134K 0.05% 136
2025
Q3
$559K Sell
10,068
-2,649
-21% -$155K 0.08% 113
2025
Q2
$878K Buy
12,717
+4,256
+50% +$289K 0.14% 84
2025
Q1
$588K Buy
8,461
+807
+11% +$66.7K 0.1% 96
2024
Q4
$658K Hold
7,654
0.11% 96
2024
Q3
$911K Sell
7,654
-110
-1% -$14.7K 0.15% 79
2024
Q2
$1.11M Buy
7,764
+10
+0.1% +$1.32K 0.19% 75
2024
Q1
$996K Buy
7,754
+100
+1% +$11.9K 0.17% 76
2023
Q4
$792K Hold
7,654
0.15% 83
2023
Q3
$696K Buy
7,654
+2
+0% +$176 0.14% 81
2023
Q2
$619K Buy
7,652
+6
+0.1% +$490 0.13% 84
2023
Q1
$608K Hold
7,646
0.13% 84
2022
Q4
$517K Hold
7,646
0.13% 103
2022
Q3
$381K Sell
7,646
-874
-10% -$46.8K 0.11% 102
2022
Q2
$475K Buy
8,520
+812
+11% +$45.1K 0.14% 89
2022
Q1
$428K Buy
7,708
+72
+0.9% +$3.69K 0.12% 103
2021
Q4
$428K Hold
7,636
0.1% 104
2021
Q3
$367K Buy
7,636
+1,004
+15% +$48.5K 0.1% 100
2021
Q2
$278K Hold
6,632
0.08% 116
2021
Q1
$224K Hold
6,632
0.08% 122
2020
Q4
$232K Hold
6,632
0.09% 114
2020
Q3
$230K Hold
6,632
0.1% 109
2020
Q2
$217K Buy
+6,632
New +$212K 0.11% 102

Other funds holding NVO

Canal Capital Management's NVO Position: Q2 2026 in Review

Canal Capital Management reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $39.4K and leaving 6,524 shares worth $313K. The position accounts for 0.04% of the portfolio, ranked #184.

Canal Capital Management first reported a position in NVO in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.11M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Canal Capital Management held 6,524 shares of Novo Nordisk worth $313K as of Q2 2026.
  • Canal Capital Management sold 918 Novo Nordisk shares in Q2 2026, an estimated $39.4K.
  • Novo Nordisk made up 0.04% of Canal Capital Management's portfolio in Q2 2026, its #184 holding.
  • Canal Capital Management first reported a position in Novo Nordisk in Q2 2020 and has held it in 25 quarters since.
  • Canal Capital Management's Novo Nordisk position peaked at $1.11M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.